Argenx
ARGX
#495
Rank
โ‚น4.831 T
Marketcap
โ‚น77,315
Share price
1.22%
Change (1 day)
66.72%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,504. In 2024 the company made an earnings per share (EPS) of โ‚น1,325 an increase over its 2023 EPS that were of -โ‚น491.01.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415
2024โ‚น1,325-369.77%
2023-โ‚น491.01-60.46%
2022-โ‚น1,24263.33%
2021-โ‚น760.31-40.37%
2020-โ‚น1,275183.47%
2019-โ‚น449.82123.09%
2018-โ‚น201.6454.93%
2017-โ‚น130.1414.07%
2016-โ‚น114.0913.05%
2015-โ‚น100.91-36.34%
2014-โ‚น158.53209.04%
2013-โ‚น51.30-33.99%
2012-โ‚น77.71185.59%
2011-โ‚น27.21